Literature DB >> 20825206

Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp.

George E Chlipala1, Megan Sturdy, Aleksej Krunic, Daniel D Lantvit, Qi Shen, Kyle Porter, Steven M Swanson, Jimmy Orjala.   

Abstract

Material collected from a parkway in the city of Chicago afforded the isolation of a Nostoc species (UIC 10022A). The extract of this strain displayed significant inhibition of the 20S proteasome as well as antiproliferative activity against HT29, MCF7, NCI-H460, and SF268 cancer cell lines. A standardized dereplication protocol allowed for the rapid identification of three known (11-13) and nine new (1-9) chlorinated cylindrocyclophanes from less than 100 mg of organic extract. Scale-up isolation of 1-9 and 11-13 from a larger extract was guided by LC-UV-MS data. In addition, KBr enrichment of the culture media afforded the isolation of a brominated cylindrocyclophane (10). Biological evaluation of 1-5, 9, and 10-13 revealed a large range of activity against the 20S proteasome and allowed the determination of preliminary structure-activity relationships of the cylindrocyclophane pharmacophore.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825206      PMCID: PMC2964865          DOI: 10.1021/np100352e

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  24 in total

1.  Isolation and structure determination of nostocyclopeptides A1 and A2 from the terrestrial cyanobacterium Nostoc sp. ATCC53789.

Authors:  T Golakoti; W Y Yoshida; S Chaganty; R E Moore
Journal:  J Nat Prod       Date:  2001-01       Impact factor: 4.050

2.  Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscula.

Authors:  J Orjala; W H Gerwick
Journal:  J Nat Prod       Date:  1996-04       Impact factor: 4.050

Review 3.  Natural products from marine organisms and their associated microbes.

Authors:  Gabriele M König; Stefan Kehraus; Simon F Seibert; Ahmed Abdel-Lateff; Daniela Müller
Journal:  Chembiochem       Date:  2006-02       Impact factor: 3.164

4.  A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer.

Authors:  G D'Agostino; J del Campo; B Mellado; M A Izquierdo; T Minarik; L Cirri; L Marini; J L Perez-Gracia; G Scambia
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

Review 5.  The ubiquitin-proteasome proteolytic pathway.

Authors:  A Ciechanover
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

6.  Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer.

Authors:  Martin J Edelman; David R Gandara; Petr Hausner; Valerie Israel; Donald Thornton; Jennifer DeSanto; L Austin Doyle
Journal:  Lung Cancer       Date:  2003-02       Impact factor: 5.705

7.  Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors.

Authors:  Tahira Khan; Jimmy K Stauffer; Rebecca Williams; Julie A Hixon; Rosalba Salcedo; Erin Lincoln; Timothy C Back; Douglas Powell; Stephen Lockett; Alma C Arnold; Thomas J Sayers; Jon M Wigginton
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

8.  New peptolides from the cyanobacterium Nostoc insulare as selective and potent inhibitors of human leukocyte elastase.

Authors:  Christian Mehner; Daniela Müller; Stefan Kehraus; Stephanie Hautmann; Michael Gütschow; Gabriele M König
Journal:  Chembiochem       Date:  2008-11-03       Impact factor: 3.164

9.  In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.

Authors:  M M Wagner; D C Paul; C Shih; M A Jordan; L Wilson; D C Williams
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

10.  Discovery and characterization of a marine bacterial SAM-dependent chlorinase.

Authors:  Alessandra S Eustáquio; Florence Pojer; Joseph P Noel; Bradley S Moore
Journal:  Nat Chem Biol       Date:  2007-12-02       Impact factor: 15.040

View more
  20 in total

1.  Anti-MRSA-acting carbamidocyclophanes H-L from the Vietnamese cyanobacterium Nostoc sp. CAVN2.

Authors:  Michael Preisitsch; Kirsten Harmrolfs; Hang T L Pham; Stefan E Heiden; Anna Füssel; Christoph Wiesner; Alexander Pretsch; Monika Swiatecka-Hagenbruch; Timo H J Niedermeyer; Rolf Müller; Sabine Mundt
Journal:  J Antibiot (Tokyo)       Date:  2014-09-03       Impact factor: 2.649

2.  Bioassay-guided isolation of constituents of Piper sarmentosum using a mitochondrial transmembrane potential assay.

Authors:  Li Pan; Susan Matthew; Daniel D Lantvit; Xiaoli Zhang; Tran Ngoc Ninh; Heebyung Chai; Esperanza J Carcache de Blanco; Djaja D Soejarto; Steven M Swanson; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2011-10-05       Impact factor: 4.050

3.  Merocyclophanes C and D from the Cultured Freshwater Cyanobacterium Nostoc sp. (UIC 10110).

Authors:  Daniel S May; Wei-Lun Chen; Daniel D Lantvit; Xiaoli Zhang; Aleksej Krunic; Joanna E Burdette; Alessandra Eustaquio; Jimmy Orjala
Journal:  J Nat Prod       Date:  2017-03-02       Impact factor: 4.050

4.  Stigonemapeptin, an Ahp-containing depsipeptide with elastase inhibitory activity from the bloom-forming freshwater cyanobacterium Stigonema sp.

Authors:  Hahk-Soo Kang; Aleksej Krunic; Jimmy Orjala
Journal:  J Nat Prod       Date:  2012-04-06       Impact factor: 4.050

5.  Minutissamides E-L, antiproliferative cyclic lipodecapeptides from the cultured freshwater cyanobacterium cf. Anabaena sp.

Authors:  Hahk-Soo Kang; Megan Sturdy; Aleksej Krunic; Hyunjung Kim; Qi Shen; Steven M Swanson; Jimmy Orjala
Journal:  Bioorg Med Chem       Date:  2012-08-22       Impact factor: 3.641

6.  Cylindrocyclophane biosynthesis involves functionalization of an unactivated carbon center.

Authors:  Hitomi Nakamura; Hilary A Hamer; Gopal Sirasani; Emily P Balskus
Journal:  J Am Chem Soc       Date:  2012-11-02       Impact factor: 15.419

7.  Ribocyclophanes A-E, Glycosylated Cyclophanes with Antiproliferative Activity from Two Cultured Terrestrial Cyanobacteria.

Authors:  Daniel S May; Hahk-Soo Kang; Bernard D Santarsiero; Aleksej Krunic; Qi Shen; Joanna E Burdette; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2018-01-30       Impact factor: 4.050

8.  Biosynthesis-assisted structural elucidation of the bartolosides, chlorinated aromatic glycolipids from cyanobacteria.

Authors:  Pedro N Leão; Hitomi Nakamura; Margarida Costa; Alban R Pereira; Rosário Martins; Vitor Vasconcelos; William H Gerwick; Emily P Balskus
Journal:  Angew Chem Int Ed Engl       Date:  2015-07-31       Impact factor: 15.336

9.  A new strategy for aromatic ring alkylation in cylindrocyclophane biosynthesis.

Authors:  Hitomi Nakamura; Erica E Schultz; Emily P Balskus
Journal:  Nat Chem Biol       Date:  2017-06-26       Impact factor: 15.040

10.  The impact of culture conditions on growth and metabolomic profiles of freshwater cyanobacteria.

Authors:  Camila M Crnkovic; Daniel S May; Jimmy Orjala
Journal:  J Appl Phycol       Date:  2017-09-14       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.